Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 9 November 1984:
Vol. 226. no. 4675, pp. 705 - 707
DOI: 10.1126/science.6093254
Prev | Table of Contents | Next

Articles

Science, Vol 226, Issue 4675, 705-707
Copyright © 1984 by American Association for the Advancement of Science

articles

Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor

RF Tucker, GD Shipley, HL Moses, and RW Holley

Purified growth inhibitor from BSC-1 cells and type beta transforming growth factor from human platelets are shown to have nearly identical biological activity and to compete for binding to the same cell membrane receptor. These findings suggest that the growth inhibitor and the type beta transforming growth factor are similar molecules. The data also show that the same purified polypeptide can either stimulate or inhibit cell proliferation depending on the experimental conditions.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
TG-interacting factor is required for the differentiation of preadipocytes.
T. Horie, K. Ono, M. Kinoshita, H. Nishi, K. Nagao, T. Kawamura, Y. Abe, H. Wada, A. Shimatsu, T. Kita, et al. (2008)
J. Lipid Res. 49, 1224-1234
   Abstract »    Full Text »    PDF »
Involvement of Fibroblast Growth Factor Receptor 2 Isoform Switching in Mammary Oncogenesis.
J. Y. Cha, Q. T. Lambert, G. W. Reuther, and C. J. Der (2008)
Mol. Cancer Res. 6, 435-445
   Abstract »    Full Text »    PDF »
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.
G. C. Daginakatte and D. H. Gutmann (2007)
Hum. Mol. Genet. 16, 1098-1112
   Abstract »    Full Text »    PDF »
Inhibition of Transforming Growth Factor-{beta} Signaling in Human Cancer: Targeting a Tumor Suppressor Network as a Therapeutic Strategy..
S. Biswas, T. L. Criswell, S. E. Wang, and C. L. Arteaga (2006)
Clin. Cancer Res. 12, 4142-4146
   Full Text »    PDF »
Requirement for the SnoN Oncoprotein in Transforming Growth Factor {beta}-Induced Oncogenic Transformation of Fibroblast Cells.
Q. Zhu, S. Pearson-White, and K. Luo (2005)
Mol. Cell. Biol. 25, 10731-10744
   Abstract »    Full Text »    PDF »
Non-Smad TGF-{beta} signals.
A. Moustakas and C.-H. Heldin (2005)
J. Cell Sci. 118, 3573-3584
   Abstract »    Full Text »    PDF »
Transforming Growth Factor {beta} (TGF-{beta})-Smad Target Gene Protein Tyrosine Phosphatase Receptor Type Kappa Is Required for TGF-{beta} Function.
S. E. Wang, F. Y. Wu, I. Shin, S. Qu, and C. L. Arteaga (2005)
Mol. Cell. Biol. 25, 4703-4715
   Abstract »    Full Text »    PDF »
Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation.
G. R. Grotendorst and M. R. Duncan (2005)
FASEB J 19, 729-738
   Abstract »    Full Text »    PDF »
MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-{beta} signaling.
F. Lin, J. M. Morrison, W. Wu, and H. J. Worman (2005)
Hum. Mol. Genet. 14, 437-445
   Abstract »    Full Text »    PDF »
Dual Role of Transforming Growth Factor {beta} in Mammary Tumorigenesis and Metastatic Progression.
R. S. Muraoka-Cook, N. Dumont, and C. L. Arteaga (2005)
Clin. Cancer Res. 11, 937s-943s
   Abstract »    Full Text »    PDF »
Overexpression of HER2 (erbB2) in Human Breast Epithelial Cells Unmasks Transforming Growth Factor {beta}-induced Cell Motility.
Y. Ueda, S. Wang, N. Dumont, J. Y. Yi, Y. Koh, and C. L. Arteaga (2004)
J. Biol. Chem. 279, 24505-24513
   Abstract »    Full Text »    PDF »
Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation.
G. R. GROTENDORST, H. RAHMANIE, and M. R. DUNCAN (2004)
FASEB J 18, 469-479
   Abstract »    Full Text »    PDF »
The Effect of TGF-{beta}1 on Differential Gene Expression Profiles in Human Corneal Epithelium Studied by cDNA Expression Array.
S. Hayashida-Hibino, H. Watanabe, K. Nishida, M. Tsujikawa, T. Tanaka, Y. Hori, Y. Saishin, and Y. Tano (2001)
Invest. Ophthalmol. Vis. Sci. 42, 1691-1697
   Abstract »    Full Text »    PDF »
Role of cytokines in the pathogenesis of posterior capsule opacification.
W R MEACOCK, D J SPALTON, and M R STANFORD (2000)
Br. J. Ophthalmol. 84, 332-336
   Full Text »
Targeted Disruption in Murine Cells Reveals Variable Requirement for Smad4 in Transforming Growth Factor beta -related Signaling.
C. Sirard, S. Kim, C. Mirtsos, P. Tadich, P. A. Hoodless, A. Itie, R. Maxson, J. L. Wrana, and T. W. Mak (2000)
J. Biol. Chem. 275, 2063-2070
   Abstract »    Full Text »    PDF »
Tyrosine Phosphorylation Regulates H2O2 Production in Lung Fibroblasts Stimulated by Transforming Growth Factor beta 1.
V. J. Thannickal, K. D. L. Aldweib, and B. L. Fanburg (1998)
J. Biol. Chem. 273, 23611-23615
   Abstract »    Full Text »    PDF »
Inhibition of TGF-ß-stimulated CTGF gene expression and anchorage-independent growth by cAMP identifies a CTGF-dependent restriction point in the cell cycle.
D. Kothapalli, N. Hayashi, and G. R. Grotendorst (1998)
FASEB J 12, 1151-1161
   Abstract »    Full Text »
Concomitant Expression of Hepatocyte Growth Factor/Scatter Factor and the Receptor c-MET in Human Myeloma Cell Lines.
M. Borset, E. Lien, T. Espevik, E. Helseth, A. Waage, and A. Sundan (1996)
J. Biol. Chem. 271, 24655-24661
   Abstract »    Full Text »    PDF »
Processing of Transforming Growth Factor [IMAGE]1 Precursor by Human Furin Convertase.
C. M. Dubois, M.-Hélèn. Laprise, F. Blanchette, L. E. Gentry, and R. Leduc (1995)
J. Biol. Chem. 270, 10618-10624
   Abstract »    Full Text »    PDF »
Concerted action of TGF-beta 1 and its type II receptor in control of epidermal homeostasis in transgenic mice..
W Cui, D J Fowlis, F M Cousins, E Duffie, S Bryson, A Balmain, and R J Akhurst (1995)
Genes & Dev. 9, 945-955
   Abstract »    PDF »
Epiregulin.
H. Toyoda, T. Komurasaki, D. Uchida, Y. Takayama, T. Isobe, T. Okuyama, and K. Hanada (1995)
J. Biol. Chem. 270, 7495-7500
   Abstract »    Full Text »    PDF »
TGF beta 1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures.
R Serra, R. Pelton, and H. Moses (1994)
Development 120, 2153-2161
   Abstract »    PDF »
Autocrine Secretion--10 Years Later.
M. B. Sporn and A. B. Roberts (1992)
Ann Intern Med 117, 408-414
   Abstract »    PDF »
c-myc and pRB: Role in TGF-{beta}1 Inhibition of Keratinocyte Proliferation.
C.S. Murphy, J.A. Pietenpol, K. Munger, P.M. Howley, and H.L. Moses (1991)
Cold Spring Harb Symp Quant Biol 56, 129-135
   Abstract »    PDF »
Mesenchymal Cell Growth Factors.
D. T. Graves and D. L. Cochran (1990)
Critical Reviews in Oral Biology & Medicine 1, 17-36
   Full Text »    PDF »
Identification of monocyte chemotactic activity produced by malignant cells.
D. Graves, Y. Jiang, M. Williamson, and A. Valente (1989)
Science 245, 1490-1493
   Abstract »    PDF »
Production of mammastatin, a tissue-specific growth inhibitor, by normal human mammary cells.
P. Ervin Jr, M. Kaminski, R. Cody, and M. Wicha (1989)
Science 244, 1585-1587
   Abstract »    PDF »
Mesoderm induction in amphibians: the role of TGF-beta 2-like factors.
F Rosa, A. Roberts, D Danielpour, L. Dart, M. Sporn, and I. Dawid (1988)
Science 239, 783-785
   Abstract »    PDF »
Extended culture of mouse embryo cells without senescence: inhibition by serum.
D. Loo, J. Fuquay, C. Rawson, and D. Barnes (1987)
Science 236, 200-202
   Abstract »    PDF »
Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets.
R. Heimark, D. Twardzik, and S. Schwartz (1986)
Science 233, 1078-1080
   Abstract »    PDF »
Transforming growth factor-beta: biological function and chemical structure.
M. Sporn, A. Roberts, L. Wakefield, and R. Assoian (1986)
Science 233, 532-534
   Abstract »    PDF »
Tumor Necrosis Factors: Gene Structure and Biological Activities.
D.V. Goeddel, B.B. Aggarwal, P.W. Gray, D.W. Leung, G.E. Nedwin, M.A. Palladino, J.S. Patton, D. Pennica, H.M. Shepard, B.J. Sugarman, et al. (1986)
Cold Spring Harb Symp Quant Biol 51, 597-609
   Abstract »    PDF »
Development of Mullerian Inhibiting Substance as an Anti-cancer Drug.
R.L. Cate, E.G. Ninfa, D.J. Pratt, D.T. MacLaughlin, and P.K. Donahoe (1986)
Cold Spring Harb Symp Quant Biol 51, 641-647
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)